Jan W Eriksson

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Venues

Diabetes, obesity & metabolism

Metabolites

Diabetologia

The Journal of clinical endocrinology and metabolism

Umeå Universitet

University of Gothenburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Umeå Universitet

Sweden

Assisting Chief (incl line management) at the Division of Endocrinology, Diabetology and Emergency Medicine (approx 100 employees) :: Depart of Medicine

Uppsala University Hospital Sep 01 2013

Sweden

Professor in Clinical Diabetes Research (full permanent position) and Chair of Clinical Diabetes and Metabolism at Dept of Medical Sciences, Uppsala University. Senior Consultant Physician (överläkare) at the section of Endocrinology and Diabetology

Uppsala University Hospital

Sweden

Adjunct Professor in Clinical Diabetes Research (part-time 20%)

AstraZeneca

Sweden

Global Medical Science Director, Clinical Discovery, Cardiovascular/Gastrointestinal Therapy Area. Subsequent 20% assignment until June 2014.

AstraZeneca

Sweden

Global Medical Science Director, Emerging Diabetes & Obesity, Clinical Development, Cardiovascular/Gastrointestinal Therapy Area

University of Gothenburg

Sweden

Adjunct Professor in Internal Medicine (part-time 20%)

AstraZeneca

Sweden

Disease area clinical expert in diabetes and dyslipidemia and Principal Scientist/Senior Principal Scientist, Discovery Medicine (early development and translational medicine)

Umeå Universitet

Sweden

Full professor in Internal Medicine (permanent position, mainly on leave for industry assignment)

Umeå University Hospital

Sweden

Senior consultant physician. Head of the Diabetes Unit and the Metabolic Unit (line management, approx 25 employees) :: Depart of Medicine

Umeå University Hospital

Sweden

Assisting Chief (incl line management) at the Division of Endocrinology, Diabetology and Emergency Medicine (approx 100 employees) :: Depart of Medicine

Lund University Hospital

Sweden

Head of the Division of Diabetology and Endocrinology (incl line management, approx 70 employees) and Deputy Head at the Dept of Endocrinology and Gastroenterology. Senior consultant physician. (six months)

Umeå Universitet

Sweden

Senior lecturer (universitetslektor) :: Depart of Medicine

Umeå Universitet

Sweden

Senior lecturer (universitetslektor) :: Depart of Medicine

Sahlgrenska universitetssjukhuset

Sweden

Physician (specialist/consultant) :: Dept of Medicine

Sahlgrenska universitetssjukhuset

Sweden

Physician (registrar/ST) :: Dept of Medicine

Varberg Hospital

Sweden

Physician (internship/AT)

Umeå Universitet

Sweden

Assisting teacher :: Dept of Anatomy

Education History

University of Gothenburg

Sweden

PHD

University of Gothenburg

Sweden

PHD

Publications

Argyri Mathioudaki, Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance. Metabolites 14 (8) (2024)
Maria João Pereira, Argyri Mathioudaki, Alicia G Otero, Padma Priya Duvvuri, Milica Vranic, Amir Sedigh, Jan W Eriksson, Maria K Svensson
Renal sinus adipose tissue: exploratory study of metabolic features and transcriptome compared with omental and subcutaneous adipose tissue. Obesity (Silver Spring, Md.) (2024)
Argyri Mathioudaki, Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance. Metabolites 14 (8) (2024)
Jan W Eriksson, Maria João Pereira, Christakis Kagios, Sofia Kvernby, Elin Lundström, Giovanni Fanni, Martin H Lundqvist, Björn C L Carlsson, Magnus Sundbom, Sambit Tarai, Mark Lubberink, Joel Kullberg, Ulf Risérus, Håkan Ahlström
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18 F-FDG-PET/MRI. Diabetologia 67 (7) (2024)
Jan W Eriksson, Maria João Pereira, Christakis Kagios, Sofia Kvernby, Elin Lundström, Giovanni Fanni, Martin H Lundqvist, Björn C L Carlsson, Magnus Sundbom, Sambit Tarai, Mark Lubberink, Joel Kullberg, Ulf Risérus, Håkan Ahlström
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18 F-FDG-PET/MRI. Diabetologia 67 (7) (2024)
Argyri Mathioudaki, Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance. Metabolites 14 (8) (2024)
Jan W Eriksson, Maria João Pereira, Christakis Kagios, Sofia Kvernby, Elin Lundström, Giovanni Fanni, Martin H Lundqvist, Björn C L Carlsson, Magnus Sundbom, Sambit Tarai, Mark Lubberink, Joel Kullberg, Ulf Risérus, Håkan Ahlström
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18 F-FDG-PET/MRI. Diabetologia 67 (7) (2024)
Jan W Eriksson, Maria João Pereira, Christakis Kagios, Sofia Kvernby, Elin Lundström, Giovanni Fanni, Martin H Lundqvist, Björn C L Carlsson, Magnus Sundbom, Sambit Tarai, Mark Lubberink, Joel Kullberg, Ulf Risérus, Håkan Ahlström
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18 F-FDG-PET/MRI. Diabetologia 67 (7) (2024)
Jan W Eriksson, Maria João Pereira, Christakis Kagios, Sofia Kvernby, Elin Lundström, Giovanni Fanni, Martin H Lundqvist, Björn C L Carlsson, Magnus Sundbom, Sambit Tarai, Mark Lubberink, Joel Kullberg, Ulf Risérus, Håkan Ahlström
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18 F-FDG-PET/MRI. Diabetologia (2024)
Jan W Eriksson, Reem A Emad, Martin H Lundqvist, Niclas Abrahamsson, Maria C Kjellsson
Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis. Endocrine connections 12 (4) (2023)
Martin H Lundqvist, Maria João Pereira, Jan W Eriksson
Glucose-dependent inflammatory responses in obese compared to lean individuals. Endocrine (2023)
Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Metabolites 13 (1) (2023)
Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Metabolites 13 (1) (2023)
Martin H Lundqvist, Maria João Pereira, Kristina E Almby, Susanne Hetty, Jan W Eriksson
Regulation of the cortisol axis, glucagon and growth hormone by glucose is altered in prediabetes and type 2 diabetes. The Journal of clinical endocrinology and metabolism (2023)
Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Metabolites 13 (1) (2023)
Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Metabolites 13 (1) (2023)
Giovanni Fanni, Jan W Eriksson, Maria João Pereira
Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Metabolites 13 (1) (2023)
Jan W Eriksson, Björn Eliasson, Louise Bennet, Johan Sundström
Registry-based randomised clinical trials: a remedy for evidence-based diabetes care? Diabetologia 65 (10) (2022)
Anna Norhammar, Johan Bodegard, Jan W Eriksson, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Avraham Karasik, Pavlos Mamouris, Navdeep Tangri, Tiago Taveira-Gomes, Aldo P Maggioni, Manuel Botana, Marcus Thuresson, Suguru Okami, Toshitaka Yajima, Takashi Kadowaki, Kåre Inge Birkeland, null null
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries. Diabetes, obesity & metabolism 24 (7) (2022)
Giovanni Fanni, Christakis Kagios, Erika Roman, Magnus Sundbom, Johan Wikström, Sven Haller, Jan W Eriksson
Effects of gastric bypass surgery on brain connectivity responses to hypoglycemia. Endocrine (2022)
Fozia Z Ahmed, Prasad G Kamble, Susanne Hetty, Giovanni Fanni, Milica Vranic, Assel Sarsenbayeva, Robin Kristófi, Kristina Almby, Maria K Svensson, Maria J Pereira, Jan W Eriksson
Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women. The Journal of clinical endocrinology and metabolism 107 (5) (2022)
Jan W Eriksson
Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes. Metabolites 12 (7) (2022)
Fozia Ahmed, Susanne Hetty, Milica Vranic, Giovanni Fanni, Joel Kullberg, Maria João Pereira, Jan W Eriksson
ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation. Adipocyte 11 (1) (2022)
Giovanni Fanni, Petros Katsogiannos, Bipasha Nandi Jui, Magnus Sundbom, Susanne Hetty, Maria João Pereira, Jan W Eriksson
Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass. Endocrine connections 11 (8) (2022)
Kristina E Almby, Petros Katsogiannos, Maria J Pereira, F Anders Karlsson, Magnus Sundbom, Urban Wiklund, Prasad G Kamble, Jan W Eriksson
Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Kristina E Almby, Martin H Lundqvist, Niclas Abrahamsson, Sofia Kvernby, Markus Fahlström, Maria J Pereira, Malin Gingnell, F Anders Karlsson, Giovanni Fanni, Magnus Sundbom, Urban Wiklund, Sven Haller, Mark Lubberink, Johan Wikström, Jan W Eriksson
Effects of Gastric Bypass Surgery on the Brain: Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity, and Cognitive Function During Normo- and Hypoglycemia. Diabetes 70 (6) (2021)
Robin Kristófi, Johan Bodegard, Anna Norhammar, Marcus Thuresson, David Nathanson, Thomas Nyström, Kåre Inge Birkeland, Jan W Eriksson
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study. Diabetes care 44 (5) (2021)
Jan W Eriksson, Robin Visvanathar, Joel Kullberg, Robin Strand, Stanko Skrtic, Simon Ekström, Mark Lubberink, Martin H Lundqvist, Petros Katsogiannos, Maria J Pereira, Håkan Ahlström
Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: whole-body PET/MRI during hyperinsulinemia. European journal of endocrinology 184 (6) (2021)
Kåre Inge Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal-Pantaler, Jetty A Overbeek, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes, obesity & metabolism 22 (9) (2020)
Kåre Inge Birkeland, Johan Bodegard, Amitava Banerjee, Dae-Jung Kim, Anna Norhammar, Jan W Eriksson, Marcus Thuresson, Suguru Okami, Kyoung Hwa Ha, Nils Kossack, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes, obesity & metabolism 23 (1) (2020)
Skander Tahar Mulder, Ann Hammarstedt, Sunil B Nagaraj, Viji Nair, Wenjun Ju, Jonatan Hedberg, Peter J Greasley, Jan W Eriksson, Jan Oscarsson, Hiddo J Lambers Heerspink
A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes. Diabetes, obesity & metabolism 22 (7) (2020)
Martin H Lundqvist, Kristina E Almby, Urban Wiklund, Niclas Abrahamsson, Prasad G Kamble, Maria João Pereira, Jan W Eriksson
Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes. Diabetologia 64 (3) (2020)
Anna Norhammar, Johan Bodegard, Thomas Nyström, Marcus Thuresson, Klas Rikner, David Nathanson, Jan W Eriksson
Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study. Diabetes, obesity & metabolism 21 (12) (2019)
Anna Norhammar, Johan Bodegard, Thomas Nyström, Marcus Thuresson, S David Nathanson, Jan W Eriksson
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study. Diabetes, obesity & metabolism 21 (5) (2019)
Ana Catarina R G Fonseca, Eugénia Carvalho, Jan W Eriksson, Maria João Pereira
Calcineurin is an important factor involved in glucose uptake in human adipocytes. Molecular and cellular biochemistry 445 (1-2) (2018)
Maria J Pereira, Per Lundkvist, Prasad G Kamble, Joey Lau, Julian G Martins, C David Sjöström, Volker Schnecke, Anna Walentinsson, Eva Johnsson, Jan W Eriksson
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (4) (2018)
Thomas Nyström, Johan Bodegard, Thomas Nyström, Marcus Thuresson, Anna Norhammar, Jan W Eriksson
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes care 41 (6) (2018)
Frederik Persson, Johan Bodegard, Jorma T Lahtela, Thomas Nyström, Marit E Jørgensen, Majken Linneman Jensen, Hanne L Gulseth, Marcus Thuresson, Fabian Hoti, David Nathanson, Anna Norhammar, Kåre Inge Birkeland, Johan G Eriksson, Jan W Eriksson
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study. Endocrinology, diabetes & metabolism 1 (4) (2018)
Frederik Persson, Thomas Nyström, Marit E Jørgensen, Bendix Carstensen, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Jan W Eriksson, Anna Norhammar, Johan Bodegard, Kåre I Birkeland
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study. Diabetes, obesity & metabolism 20 (2) (2017)
Thomas Nyström, Johan Bodegard, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W Eriksson
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes. Diabetes, obesity & metabolism 19 (6) (2017)
Per Lundkvist, Maria J Pereira, Petros Katsogiannos, C David Sjöström, Eva Johnsson, Jan W Eriksson
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes, obesity & metabolism 19 (9) (2017)

Jan W Eriksson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jan W Eriksson